NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1255606489 M.D.
Verify on CMS → Lindsay Collins, M.D.
Endocrinology, Diabetes & Metabolism Physician in Kirkland, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 248 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
53%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
78.2/100
▼ 5 pts below national avg 83.5 · Above neutral
Industry payments
$46.16
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Lindsay Collins, M.D. reported a CMS MIPS final score of 78.2/100 - below the 83.5 national average - and filed 1,536 Medicare Part D claims in 2024.
- 78.2/100
- MIPS score · -5 vs avg
- 2K
- Part D claims, 2024
- 53%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Lindsay Collins, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1255606489), first enumerated 03/21/2012.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,536 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 78.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$46.16 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Washington statewide board action statistics are published annually — these figures describe aggregate state activity, not Lindsay Collins, M.D.'s individual license status. Verify directly with the state medical board.
Source: WMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1255606489 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1255606489
- ENUM-MID 2012
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-BELOW 78.2/100
- RX-MID 1,536
- BOOK-THIN 181 in Washington
- PHOTO-FINISH Diana Barb · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Amer Kassar · lo…
Amer Kassar
78.1 MIPS pts
- Collins · this p…
Collins · this provider
78.2 MIPS pts
- William Donahoo …
William Donahoo
78.2 MIPS pts
- Diana Barb · near
Diana Barb
78.2 MIPS pts
- Kenneth Cusi · n…
Kenneth Cusi
78.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Lindsay Collins, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
78 ≥ 23rd percentile 23% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lindsay Collins, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lindsay Collins, M.D. writes more Part D claims than 37% of them and scores higher on MIPS quality than 24% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Lindsay Collins, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Lindsay Collins, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lindsay Collins, M.D.?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,536 44% vs specialty avg
MIPS final score
78.2/100 5.3 pts vs avg
Specialty distribution in Washington
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Washington providers
Medicare quality performance, MIPS
Lindsay Collins, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 78.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1255606489 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 03/21/2012 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
78.1574
Final Score
Measured-score avg: 83.5
85.2963
Quality
41.895
Cost
100
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lindsay Collins, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$46
Largest payer
Tandem Diabetes Care, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Lindsay Collins, M.D.. To verify Lindsay Collins, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Lindsay Collins, M.D. - brand share 42.0%
Endocrinology, Diabetes & Metabolism Physician average
42% brand-name claims vs 53% generic, on 1,536 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,536
Total Claims
$580K
Total Drug Cost
248
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,756.233
- Total Day Supply
- 111,583
- Brand vs Generic
- 42% brand / 53% generic
- Brand Drug Cost
- $514K
- Generic Drug Cost
- $24K
Patient Demographics
- Average Patient Age
- 73.7 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 17, 65-74: 124, 75-84: 86, 85+: 21
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Lindsay Collins, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
242 claims
- Alendronate Sodium
Alendronate Sodium
107 claims
- Methimazole
Methimazole
103 claims
- Metformin Hcl 80
Metformin Hcl
80 claims
- Metformin Hcl Er 67
Metformin Hcl Er
67 claims
- Ozempic 57
Ozempic
57 claims
- Synthroid 46
Synthroid
46 claims
- Lantus Solostar 45
Lantus Solostar
45 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 242 |
| Alendronate Sodium | 107 |
| Methimazole | 103 |
| Metformin Hcl | 80 |
| Metformin Hcl Er Metformin Hcl | 67 |
| Ozempic Semaglutide | 57 |
| Synthroid Levothyroxine Sodium | 46 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 45 |
| Hydrocortisone | 39 |
| Jardiance Empagliflozin | 34 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in WA →
All providers in Washington →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Lindsay Collins, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Lindsay Collins, M.D.'s 1,536 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Collins, both outside Washington so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (78.2 here).
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Collins.
One of 181 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Washington, 5 are shown here.
Sonia Afshariyamchlou
Richland, WA
Tanya Aggarwal
Silverdale, WA
Dr. Iram Ahmad
M.D.
Seattle, WA
Dr. Mandana Ahmadian
MD
Bellevue, WA
Dr. Anam Akmal
M.D
Lacey, WA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Lindsay Collins, M.D.'s specialty? ▼
Lindsay Collins, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Kirkland, Washington. Credentials: M.D..
How much does Lindsay Collins, M.D. prescribe under Medicare Part D? ▼
In 2024, Lindsay Collins, M.D. wrote 1,536 Medicare Part D claims totaling $580K in drug costs for 248 beneficiaries.
What is Lindsay Collins, M.D.'s Medicare quality score? ▼
Lindsay Collins, M.D. has a CMS MIPS Final Score of 78.2/100 (Quality: 85.3, Cost: 41.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Lindsay Collins, M.D. located? ▼
Lindsay Collins, M.D. is located at 12303 NE 130TH LN STE 250, Kirkland, WA, 98034. Phone: (425) 899-6415.
What is Lindsay Collins, M.D.'s NPI number? ▼
Lindsay Collins, M.D.'s National Provider Identifier (NPI) is 1255606489, issued on 03/21/2012.
Does Lindsay Collins, M.D. prescribe more brand-name or generic drugs? ▼
Lindsay Collins, M.D.'s prescribing is 42% brand-name and 53% generic drugs by claim count, with $514K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Lindsay Collins, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Lindsay Collins, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Alendronate Sodium, Methimazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lindsay Collins, M.D. accept Medicare? ▼
Lindsay Collins, M.D. appears in CMS Medicare data with 1,536 Part D claims and 248 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lindsay Collins, M.D.'s credentials? ▼
Lindsay Collins, M.D.'s NPI is 1255606489 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.